[
  {
    "id": "Samad2016",
    "doi": "10.1093/eurheartj/ehv701",
    "n": 1090,
    "treated_total": 287,
    "treated_total_window": "within five years; not the number treated within 90 days",
    "control_n": null,
    "hr": 0.59,
    "lower": 0.44,
    "upper": 0.78,
    "estimate_source": "Table 4, mean-gradient moderate AS, IPW AVR within 90 days",
    "alternative_hr": 0.68,
    "alternative_lower": 0.52,
    "alternative_upper": 0.9,
    "alternative_source": "Table 4, five-year time-dependent AVR model",
    "category": "mixed_severity",
    "ef": "LVEF <=50%",
    "procedure": "SAVR with or without CABG",
    "entry_definition": "Mean gradient 25-39 mm Hg and/or peak velocity 3 to <4 m/s; AVA classification also analyzed separately.",
    "window": "Primary synthesis input: AVR within 90 days; median delay in moderate-gradient AVR recipients 28 days, IQR 5-255.",
    "procedure_severity": "Among 135 isolated-AVR recipients from the moderate-gradient group, 30 had subsequent gradients >40 mm Hg and six had dobutamine-confirmed true severe AS; other discordant criteria also described. These counts describe the five-year recipient set, not necessarily the 90-day estimate.",
    "control_strategy": "No initial AVR in the 90-day IPW contrast; later AVR not explicitly excluded. Five-year main model used time-dependent AVR.",
    "time_zero": "IPW sensitivity starts at surgery for recipients and day 15 after echo for nonrecipients; primary five-year model starts at index echo with time-dependent treatment.",
    "concomitant": "152 of 287 moderate-gradient recipients had CABG; isolated-AVR patients also included other valve lesions.",
    "source_url": "https://europepmc.org/articles/PMC5841220",
    "source_location": "Methods, Statistical analysis; Results, Use of aortic valve surgery; Table 4",
    "access": "full text",
    "severity_at_treatment": "mixed documented; no separate HR for confirmed-moderate recipients",
    "delayed_control_intervention": "not quantified for 90-day comparator",
    "unknowns": "Procedure-time severity for the 90-day and AVA-defined subgroups not separated."
  },
  {
    "id": "Moon2020",
    "doi": "10.4070/kcj.2020.0037",
    "n": 255,
    "treated_total": 37,
    "treated_total_window": "within two years",
    "control_n": 218,
    "hr": 0.43,
    "lower": 0.2,
    "upper": 0.91,
    "estimate_source": "Table 3, multivariable all-cause mortality",
    "alternative_hr": 0.7,
    "alternative_lower": 0.49,
    "alternative_upper": 0.99,
    "alternative_source": "Results, inverse-probability-weighted further-adjusted sensitivity",
    "category": "early_window_unresolved",
    "ef": "LVEF <50% (text also describes <=50%)",
    "procedure": "SAVR",
    "entry_definition": "AVA 1.0-1.5 cm2 and peak velocity 2-4 m/s at the index echo.",
    "window": "AVR within two years; median 20 days and 75% within 60 days; separate 90-day sensitivity.",
    "procedure_severity": "Authors describe treatment at moderate stage, but define exposure by time from entry; explicitly use 90-day sensitivity to reduce the possibility of progression before surgery.",
    "control_strategy": "Medical observation without AVR in the defined comparison.",
    "time_zero": "Survival duration from index echocardiography; treatment classified by subsequent surgery within two years.",
    "concomitant": "26 of 37 had isolated AVR; ten had at least moderate aortic regurgitation.",
    "source_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7441005/",
    "source_location": "Methods, Study population and Statistical analysis; Results, Clinical information and sensitivity analyses",
    "access": "full text",
    "severity_at_treatment": "moderate-stage intention stated; no complete procedure-time reclassification table located",
    "delayed_control_intervention": "no AVR comparator",
    "unknowns": "Do not assume that any recipient progressed to severe; liberal coding includes this study as declared moderate-stage."
  },
  {
    "id": "Ludwig2023",
    "doi": "10.1161/CIRCINTERVENTIONS.122.012768",
    "n": 649,
    "treated_total": 179,
    "treated_total_window": "TAVR recipients in pseudo-severe subgroup",
    "control_n": 470,
    "hr": 0.39,
    "lower": 0.27,
    "upper": 0.55,
    "estimate_source": "Abstract and multivariable model including all nonsevere AS; excludes 527 true-severe TAVR recipients",
    "alternative_hr": 0.38,
    "alternative_lower": 0.24,
    "alternative_upper": 0.61,
    "alternative_source": "Adjusted pseudo-severe TAVR versus Medical-Mod group comparison",
    "category": "pseudo_severe",
    "ef": "LVEF <50%",
    "procedure": "TAVR",
    "entry_definition": "Treated low-gradient patients had AVA <=1.0 cm2; CT calcium thresholds classified pseudo-severe. Medical controls had moderate or pseudo-severe AS.",
    "window": "TAVR at registry entry; follow-up limited to two years.",
    "procedure_severity": "CT-defined nonsevere/pseudo-severe low-gradient phenotype; do not call this documented progression to true severe AS.",
    "control_strategy": "External medical registry; controls censored at AVR, including deferred intervention.",
    "time_zero": "Separate treated TAVR registry and medical echo registry; no common randomization time.",
    "concomitant": "No concomitant open surgery in TAVR arm.",
    "source_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10180023/",
    "source_location": "Methods, Patient population and Subgroups; Abstract and nonsevere multivariable analysis",
    "access": "full text",
    "severity_at_treatment": "nonsevere by CT, distinct from concordant echo-defined moderate AS",
    "delayed_control_intervention": "censored at intervention",
    "unknowns": "Potential participant overlap with later Erasmus TAVR cohorts cannot be resolved from aggregates."
  },
  {
    "id": "Hariri2024",
    "doi": "10.1136/openhrt-2024-002616",
    "n": 1421,
    "treated_total": 299,
    "treated_total_window": "during follow-up while moderate",
    "control_n": 1122,
    "hr": 0.51,
    "lower": 0.34,
    "upper": 0.77,
    "estimate_source": "Abstract and adjusted survival analysis, all-cause mortality",
    "category": "explicit_moderate",
    "ef": "All EF except <20%",
    "procedure": "220 SAVR, 79 TAVR",
    "entry_definition": "AVA 1.0-1.5 cm2; age >=65; bicuspid excluded.",
    "window": "Any AVR during follow-up while still moderate; no fixed early-treatment window.",
    "procedure_severity": "Flow diagram explicitly excludes 265 severe-AS AVR recipients; included 299 moderate-AS AVR recipients.",
    "control_strategy": "Patients without AVR during follow-up; severe-stage AVR recipients excluded from the cohort.",
    "time_zero": "Baseline/echo data at surgery for AVR recipients and at first echo for surveillance; survival comparison not a baseline-randomized strategy.",
    "concomitant": "78 of 299 had concomitant open-heart surgery; 57 had CABG.",
    "source_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11110558/",
    "source_location": "Figure 1 caption; Methods, Study groups and Study variables; Results",
    "access": "full text",
    "severity_at_treatment": "explicit moderate at preoperative echo",
    "delayed_control_intervention": "not retained as a deferred-treatment strategy",
    "unknowns": "Requiring an echo at least two years after index adds selection; no new individual-level bias correction is possible."
  },
  {
    "id": "Adrichem2025",
    "doi": "10.1016/j.amjcard.2025.05.032",
    "n": 335,
    "treated_total": 115,
    "treated_total_window": "TAVR for moderate AS",
    "control_n": 220,
    "hr": 0.51,
    "lower": 0.35,
    "upper": 0.76,
    "estimate_source": "Multivariable primary mortality model, Figure 2 and central illustration",
    "alternative_hr": 0.5,
    "alternative_lower": 0.33,
    "alternative_upper": 0.75,
    "alternative_source": "Propensity-matched analysis of 71 pairs; residual NYHA imbalance acknowledged",
    "category": "explicit_moderate",
    "ef": "All EF; median 60%",
    "procedure": "TAVR",
    "entry_definition": "AVA 1.0-1.5 cm2 or velocity 2.5-4 m/s with AVA >1.0 cm2; AVA <1.0 low-gradient AS excluded.",
    "window": "Treated symptomatic patients referred for suspected severe AS, re-reviewed as moderate before TAVR.",
    "procedure_severity": "Echo-defined moderate at treatment; discussion notes frequent severe-range calcium scores among those scanned.",
    "control_strategy": "Surveillance permits delayed valve intervention, principally for progression to severe AS; subsequent moderate-stage exceptions also reported.",
    "time_zero": "TAVR referrals compared with an echo-database surveillance cohort; exact aligned eligibility time not explicitly specified in the available methods.",
    "concomitant": "TAVR arm has no concomitant open surgery; comparator includes later open operations.",
    "source_url": "https://pure.amsterdamumc.nl/files/150630561/Transcatheter-aortic-valve-replacement-for-patients-with-moderate-aortic-stenos-isa-propensity-matched-analysis.pdf",
    "source_location": "Methods, Study design and Statistical analysis; Results, Aortic valve interventions; Discussion, Limitations",
    "access": "full published PDF text through public university repository",
    "severity_at_treatment": "explicit echo-defined moderate",
    "delayed_control_intervention": "74 of 220 underwent delayed valve intervention: 62 after severe progression (including two balloon valvuloplasties), 12 while moderate",
    "unknowns": "The reported count 74/220 is retained; do not reuse an internally inconsistent printed percentage. Referral and baseline confounding remain."
  },
  {
    "id": "Angellotti2025",
    "doi": "10.1016/j.jcin.2025.08.018",
    "n": 343,
    "treated_total": 122,
    "treated_total_window": "during follow-up",
    "control_n": 221,
    "hr": 0.46,
    "lower": 0.31,
    "upper": 0.68,
    "estimate_source": "Majed supplemental Table 12 combines early-CD and advanced-CD strata; original reports HRs .61 (.25-1.44) and .43 (.28-.66)",
    "category": "mixed_severity",
    "ef": "All EF",
    "procedure": "85 TAVR, 37 SAVR among moderate-entry recipients",
    "entry_definition": "Moderate AVA <=1.5 cm2 or mean gradient >=20 mm Hg, with severe categories separated.",
    "window": "AVR after median 749 days in moderate-entry group.",
    "procedure_severity": "Preoperative echo available in 116 of 122 recipients; 22 of 116 progressed to severe; 94 did not, six unclassified.",
    "control_strategy": "Conservative patients compared with eventual AVR recipients during follow-up.",
    "time_zero": "Registry enrollment and subsequent ever-AVR classification; no time-dependent treatment model described.",
    "concomitant": "Ten of 37 surgical moderate-entry recipients had CABG and two had two-valve surgery; most registry patients had undergone PCI.",
    "source_url": "https://www.jacc.org/doi/10.1016/j.jcin.2025.08.018",
    "source_location": "Methods, Population and Statistical analysis; Results, AVR and Figure 4",
    "access": "full text",
    "severity_at_treatment": "mixed, with explicit progression counts",
    "delayed_control_intervention": "eventual AVR defines treated group",
    "unknowns": "No mortality estimate restricted to the 94 confirmed-moderate recipients is reported in the primary text."
  },
  {
    "id": "Lim2026",
    "doi": "10.1016/j.echo.2026.05.041",
    "n": 2490,
    "treated_total": 211,
    "treated_total_window": "within one year; count from Majed supplemental Table 12",
    "control_n": 2279,
    "hr": 0.67,
    "lower": 0.5,
    "upper": 0.92,
    "estimate_source": "Overall adjusted HR from Majed supplemental Table 12; primary accessible abstract gives damage-stratum HRs .45 (.26-.79) and .76 (.52-1.09)",
    "category": "early_window_unresolved",
    "ef": "All EF",
    "procedure": "AVR (procedure mix not verified from accessible primary sections)",
    "entry_definition": "AVA 1.0-1.5 cm2, velocity 3-4 m/s and mean gradient 20-40 mm Hg in accessible primary abstract.",
    "window": "Within one year of index echo; median 22 days from secondary supplement.",
    "procedure_severity": "Accessible primary abstract and snippets do not provide a complete reclassification at intervention.",
    "control_strategy": "Conservative strategy; later intervention handling not independently established from accessible primary sections.",
    "time_zero": "Index echo and early treatment within one year; secondary synthesis reports fixed exposure classification.",
    "concomitant": "Not independently ascertained from available primary excerpts.",
    "source_url": "https://www.sciencedirect.com/science/article/pii/S0894731726002555",
    "source_location": "Primary abstract and Methods/Limitations snippets; Majed supplemental Table 12 for overall HR and treatment count",
    "access": "primary abstract and section excerpts; full methods unavailable",
    "severity_at_treatment": "unresolved in accessible primary report",
    "delayed_control_intervention": "unresolved",
    "unknowns": "Primary overall estimate, procedure-time severity, full adjustment and treatment modeling not independently verified."
  }
]
